Similar articles

• Thyroid gland in Graves' disease: victim or culprit?

  Chopra IJ, Solomon DH, Johnson DE, Chopra U. Chopra IJ, et al. Metabolism. 1970 Oct;19(10):760-72. doi: 10.1016/0026-0495(70)90074-0. Metabolism. 1970. PMID: 5535910 No abstract available.
• Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.

  Prummel MF, Wiersinga WM, Mourits MP, Koornneef L, Berghout A, van der Gaag R. Prummel MF, et al. Arch Intern Med. 1990 May;150(5):1098-101. Arch Intern Med. 1990. PMID: 1691908
• Responsiveness to thyrotropin releasing hormone and thyroid suppressibility in Graves' disease patients remaining in remission after antithyroid drug therapy.

  Rajatanavin R, Mahatumarat P, Poochanugool L, Kumpolpunth S, Himathongkam T. Rajatanavin R, et al. J Med Assoc Thai. 1981 Jan;64(1):11-8. J Med Assoc Thai. 1981. PMID: 6163837 No abstract available.
• Graves' disease: xenotransplantation model (athymic nude mice).

  Jungheim K, Schumm-Draeger PM, Usadel KH. Jungheim K, et al. J Mol Med (Berl). 1999 Jan;77(1):185-8. J Mol Med (Berl). 1999. PMID: 9930960 Review.
• Concepts of pathogenesis of Graves' disease.

  Solomon DH, Kleeman KE. Solomon DH, et al. Adv Intern Med. 1977;22:273-99. Adv Intern Med. 1977. PMID: 402796 Review. No abstract available.